EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 exhibit_99-1.htm


Exhibit 99.1
 

Cimatron Reports $11 Million Revenues in Q1/14, Marking
Record First Quarter Revenues, Operating Profit
and Cash Flow
 
Givat Shmuel, Israel, – May 14th, 2014 – Cimatron Limited (NASDAQ: CIMT), a leading provider of integrated CAD/CAM software solutions for the toolmaking and manufacturing industries, today announced its financial results for the first quarter of 2014.
 
Highlights of Cimatron’s results for the first quarter of 2014 include the following:
 
 
·
40% year-over-year increase in non-GAAP operating profit, to a Q1 record of $1.4 million
 
·
Record Q1 revenues of $11 million, an 8% year-over-year increase (6.3% on constant currency basis)
 
·
16th consecutive quarter with year-over-year revenue growth on a constant currency basis
 
·
$3.2 million cash flow from operating activities; End of quarter net cash balance of $16.1 million or $1.50 per share
 
Commenting on the results, Danny Haran, President and Chief Executive Officer of Cimatron, noted, “We are very pleased to report Q1 2014 as a record first quarter. In particular, we are pleased that the year-over-year revenue growth of 8% in the quarter was translated to 40% year-over-year growth in operating profit, reflecting once again the strong operating leverage inherent in our business model.
 
“The solid growth in both revenues and operating profit, as well as the strong positive cash flow, will enable us to continue investing in product development and pursuing additional opportunities for expanding our distribution network, while continuing to look for M&A opportunities.
 
“We recently held two large reseller meetings, one for the GibbsCAM product line and one for the CimatronE product line, where the upcoming versions of both products were presented and welcomed with enthusiasm. We have a lot to look forward to in the 2014 versions, which include exciting developments for manufacturing, tool making and additive manufacturing,” concluded Mr. Haran.
 
 
 

 
 

 
The following provides details on Cimatron’s GAAP and non-GAAP results for the first quarter of 2014:
 
GAAP:
 
Revenues for the first quarter of 2014 increased by 8% to $11.0 million, from $10.2 million recorded in the first quarter of 2013.
 
Gross Profit for the first quarter of 2014 was $9.5 million, as compared to $8.8 million in the same period in 2013. Gross margin in the first quarter of 2014 constituted 86% of revenues, compared to 87% in the first quarter of 2013.
 
Operating Profit in the first quarter of 2014 increased by 38% to $1.1 million, from $0.8 million in the corresponding quarter of 2013.
 
Net Profit for the first quarter of 2014 was $0.7 million, or $0.06 per diluted share, compared to a net profit of $0.6 million, or $0.06 per diluted share, recorded in the same quarter of 2013.
 
Non-GAAP:
 
Revenues for the first quarter of 2014 increased by 8% to $11.0 million, from $10.2 million recorded in the first quarter of 2013.
 
Gross Profit for the first quarter of 2014 was $9.6 million, as compared to $9.0 million in the same period of 2013. Gross margin in the first quarter of 2014 constituted 88% of revenues, the same as in the first quarter of 2013.
 
Operating Profit in the first quarter of 2014 increased by 40% to $1.4 million, from $1.0 million in the corresponding quarter of 2013.
 
Net Profit for the first quarter of 2014 was $0.9 million, or $0.08 per diluted share, compared to net profit of $0.7 million, or $0.08 per diluted share, recorded in the same quarter of 2013.
 
 
 

 
 

 
Conference Call
 
Cimatron's management will host a conference call today, May 14, 2014, at 9:00 EDT, 16:00 Israel time. On the call, management will review and discuss the results, and will answer questions by investors.
 
To participate, please call one of the following teleconferencing numbers. Please begin placing your call at least 5 minutes before the conference call commences.

USA: +1-888-407-2553
International: +972-3-9180610
Israel: 03-9180610
 
For those unable to listen to the live call, a replay of the call will be available beginning on the day after the call at the investor relations section of Cimatron's website, at: www.cimatron.com
 
Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income included herein. Non-GAAP financial measures consist of GAAP financial measures adjusted to include recognition of deferred revenues of acquired companies and to exclude amortization of acquired intangible assets, stock based compensation and deferred income tax, as well as certain business combination and other accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-cash charges and other items that are considered by management to be outside of our core operating results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP. Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. We believe that these non-GAAP measures help investors to understand our current and future operating performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies.
 
About Cimatron
 
With over 30 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM software solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles and ultimately shorten product delivery time.
 
 
 

 
 

 
The Cimatron product line includes the CimatronE and GibbsCAM brands with software solutions for mold design, die design, electrode design, 2.5 to 5 Axis milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.
 
Cimatron's shares are publicly traded on the NASDAQ under the symbol CIMT. For more information, please visit Cimatron’s web site at: http://www.cimatron.com
 
Safe Harbor Statement
 
This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron’s plans, objectives and expected financial and operating results. The words "may," "could," "would," “will,” "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron’s ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron’s business, refer to Cimatron’s filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
 
Company Contact:
Investor Relations contact
Ilan Erez, Chief Financial Officer
Ehud Helft/Kenny Green
Cimatron Ltd.
GK Investor Relations
Tel.; 972-73-237-0114
Tel: (US) 1 646 201 9246
Email: ilane@cimatron.com
Email: Cimatron@gkir.com
 
 
 

 
 
CIMATRON LIMITED
CONSOLIDATED STATEMENTS OF INCOME
(US Dollars in thousands, except for per share data)
 
   
Three months ended
 
   
March 31,
 
   
2014
   
2013
 
             
Total revenue
    10,963       10,158  
                 
Total cost of revenue
    1,503       1,326  
                 
Gross profit
    9,460       8,832  
                 
   Research and development expenses
    1,915       1,728  
                 
   Selling, general and administrative expenses
    6,474       6,326  
                 
Operating income
    1,071       778  
                 
   Financial income (expenses), net
    (39 )     16  
                 
   Taxes on income
    (350 )     (192 )
                 
   Other
    (21 )     2  
                 
Net income
    661       604  
                 
   Less: Net income attributable to the noncontrolling interest
    (10 )     -  
                 
Net income attributable to Cimatron's shareholders
  $ 651     $ 604  
                 
Net income per share - basic and diluted
  $ 0.06     $ 0.06  
                 
Weighted average number of shares outstanding
               
                 
Basic EPS (in thousands)
    10,731       9,348  
                 
Diluted EPS (in thousands)
    10,731       9,358  
 
 
 

 
 
CIMATRON LIMITED
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
(US Dollars in thousands, except for per share data)
 
   
Three months ended
 
   
March,
 
    2014     2013  
   
GAAP
   
Adj.
   
NON-GAAP
   
GAAP
   
Adj.
   
NON-GAAP
 
                                     
Total revenue
    10,963       -       10,963       10,158       -       10,158  
                                                 
Total cost of revenue (1)
    1,503       (147 )     1,356       1,326       (147 )     1,179  
                                                 
Gross profit
    9,460       147       9,607       8,832       147       8,979  
                                                 
   Research and development expenses (2)
    1,915       (12 )     1,903       1,728       -       1,728  
                                                 
   Selling, general and administrative expenses
    6,474               6,337       6,326               6,273  
Non-cash amortization of acquired intangible assets
            -                       (53 )        
Stock-based compensation
            (137 )                     -          
                                                 
Operating income
    1,071       296       1,367       778       200       978  
                                                 
   Financial income (expenses), net
    (39 )     -       (39 )     16       -       16  
                                                 
   Taxes on income (3)
    (350 )     (83 )     (433 )     (192 )     (91 )     (283 )
                                                 
   Other
    (21 )     -       (21 )     2       -       2  
                                                 
Net income
    661       213       874       604       109       713  
                                                 
   Less: Net income attributable to the noncontrolling interest
    (10 )     -       (10 )     -       -       -  
                                                 
Net income attributable to Cimatron's shareholders
  $ 651     $ 213     $ 864     $ 604     $ 109     $ 713  
                                                 
Net income per share - basic and diluted
  $ 0.06             $ 0.08     $ 0.06             $ 0.08  
                                                 
Weighted average number of shares outstanding
                                               
                                                 
Basic EPS (in thousands)
    10,731               10,731       9,348               9,348  
                                                 
Diluted EPS (in thousands)
    10,731               10,731       9,358               9,358  
 
(1) Non-GAAP adjustment to exclude non-cash amortization of acquired intangible assets
           
(2) Non-GAAP adjustment to exclude stock-based compensation
           
(3) Non-GAAP adjustment to exclude the effect of deferred taxes and other non-current tax provisions.
         
 
 
 

 
 
CIMATRON LIMITED
CONSOLIDATED BALANCE SHEETS
(US Dollars in thousands)
 
   
March 31,
   
December 31,
 
   
2014
   
2013
 
             
ASSETS
           
CURRENT ASSETS:
           
Total cash, cash equivalents and short-term investments
  $ 16,614     $ 13,052  
Trade receivables
    6,792       6,838  
Other current assets
    2,832       2,434  
Total current assets
    26,238       22,324  
                 
Deposits with insurance companies and severance pay fund
    3,719       3,725  
                 
Net property and equipment
    973       977  
                 
Net other assets
    10,272       10,407  
                 
Total assets
  $ 41,202     $ 37,433  
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
CURRENT LIABILITIES:
               
Short-term bank credit
  $ 535     $ 5  
Trade payables
    973       1,356  
Accrued expenses and other liabilities
    6,128       6,297  
Deferred revenues
    6,058       2,974  
Total current liabilities
    13,694       10,632  
                 
LONG-TERM LIABILITIES:
               
Accrued severance pay
    5,091       5,018  
Deferred tax liability
    9       69  
   Total long-term liabilities
    5,100       5,087  
                 
Total shareholders’ equity
    22,408       21,714  
Total liabilities and shareholders’ equity
  $ 41,202     $ 37,433  
 
 
 

 
 
CIMATRON LIMITED
STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(US Dollars in thousands)
 
                     
Accumulated other comprehensive income
               
Comprehensive income
       
 
Noncontrolling Interest
   
Share capital
   
Additional paid-in capital
   
Retained earnings
   
Treasury stock
   
Total shareholders’ equity
 
Balance at December 31, 2013
  $ 33     $ 350     $ 17,172     $ 88     $ 4,823     $ (752 )         $ 21,714  
Changes during the three months ended March 31, 2014:
                                                             
Net income
    10                               651               661       661  
Stock based compensation
                    149                                       149  
Other
    (43 )                     (109 )                     (152 )     (152 )
Foreign currency translation adjustment
                            36                       36       36  
Total comprehensive income
                                                    545          
Balance at March 31, 2014
  $ -     $ 350     $ 17,321     $ 15     $ 5,474     $ (752 )           $ 22,408  
 
 
 

 
 
CIMATRON LIMITED
STATEMENTS OF CASH FLOWS
(US Dollars in thousands)
 
   
Three months ended
 
   
March 31,
 
   
2014
   
2013
 
             
Cash flows from operating activities:
           
Net income
  $ 661     $ 604  
                 
Adjustments to reconcile net income
               
   to net cash provided by (used in) operating activities:
               
Depreciation and amortization
    239       293  
Increase in accrued severance pay
    62       86  
Stock based compensation
    149       -  
Deferred taxes, net
    (77 )     (90 )
                 
Changes in assets and liabilities:
               
Increase in accounts receivable and prepaid expenses
    (258 )     (1,194 )
Decrease in inventory
    5       -  
Decrease (increase) in deposits with insurance companies and severance pay fund
    6       (110 )
Increase in trade payables, accrued expenses and other liabilities
    2,425       280  
Net cash provided by (used in) operating activities
    3,212       (131 )
                 
Cash flows from investing activities:
               
Proceeds from sale of property and equipment
    -       7  
Purchase of property and equipment
    (65 )     (49 )
Net cash used in investing activities
    (65 )     (42 )
                 
Cash flows from financing activities:
               
Short-term bank credit
    509       5,658  
Purchase of non-controlling interest
    (92 )     -  
Cash distribution to shareholders
    -       (7,874 )
Net cash provided by (used in) financing activities
    417       (2,216 )
                 
Net increase (decrease) in cash and cash equivalents
    3,564       (2,389 )
Effect of exchange rate changes on cash
    (2 )     (88 )
Cash and cash equivalents at beginning of period
    13,052       11,903  
Cash and cash equivalents at end of period
  $ 16,614     $ 9,426  
                 
Appendix A - Non-cash transactions
               
Purchase of property on credit
  $ 20     $ 5